FDA Inspection
Frontida BioPharm IncFrontida BioPharm Inc – FDA Inspection, Jul 22, 2025
Record Details
This FDA Inspection record concerns Frontida BioPharm Inc, with an inspection on July 22, 2025, issued by the Center for Tobacco Products, covering tobacco.
View Company Profile
ID · be6ada2f-716c-4ddd-8b36-f7d3b7cd65b3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1279864
- FDA center
- Tobacco Products
- Project area
- Tobacco Post-Market Activities
Other FDA inspections of Frontida BioPharm Inc
14| Date | Classification | Office | Project area |
|---|---|---|---|
| April 2, 2026 | Not classified | Philadelphia District Office | |
| July 22, 2025 | NAI | Center for Tobacco Products | Tobacco Post-Market Activities |
| December 7, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 20, 2017 | Not classified | Philadelphia District Office |
Other documents for Frontida BioPharm Inc
- FDA Inspection 1316756 - 2026-04-02
- FDA Inspection 1280570 - 2025-07-22
- FDA Inspection 1226606 - 2023-12-07
- FDA Inspection 1097023 - 2019-07-19
- FDA Inspection 1030391 - 2017-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.